CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Can paramedics use FRAX (the WHO Fracture Risk Assessment Tool) to help GPs improve future fracture risk in patients who fall? Protocol for a randomised controlled feasibility study
Authors
Attride-Stirling
Borgström
+14 more
Chapuy
Copeland
Flick
Geusens
Johnell
Kanis
Manca
Masud
Mays
Newton
Patton
Snooks
Stalenhoef
Yoshida
Publication date
1 January 2014
Publisher
'BMJ'
Doi
Cite
View
on
PubMed
Abstract
© 2014, BMJ Publishing Group. All rights reserved. Introduction: Currently identification, and therefore, management of patients at risk of osteoporotic fracture in the UK is suboptimal. As the majority of patients who fracture have fallen, it follows that people who fall can usefully be targeted in any programme that aims to reduce osteoporotic fracture. Targeting vulnerable patients who are likely to benefit from intervention may help shift the management of fracture prevention into primary care, away from emergency departments. Paramedics who attend to patients who have fallen may be well placed to assess future fracture risk, using the Fracture Risk Assessment Tool (FRAX) and communicate that information directly to general practitioners (GPs). Methods and analysis: This feasibility study takes the form of a pragmatic, randomised controlled trial aimed at exploring and refining issues of study design, recruitment, retention, sample size and acceptability preceding a large-scale study with fracture as the end point. Patients (aged >50) who fall, call an ambulance, are attended by a study paramedic and give verbal consent will be asked FRAX and fall questions. Patients who subsequently formally consent to participation will be randomised to control (usual care) or intervention groups. Intervention will constitute transmission of calculated future fracture risk to the patients' GP with suitable, evidence-based recommendations for investigation or treatment. 3 months after the index fall, data ( proportion of patients in each group undergoing investigation or starting new treatment, quality of life and health economic) will be collected and analysed using descriptive statistics. A nested qualitative study will explore issues of acceptability and study design with patients, paramedics and GPs. Ethics and dissemination: This protocol was approved by NRES Committee South Central Oxford C in October 2012. Research Ethics Committee ref.12/SC/0604. The study findings will be disseminated through peer-reviewed journals, conference presentations and local public events. A publication plan and authorship criteria have been preagreed. Trial registration number: ISRCTN: 36245726
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Supporting member
Explore Bristol Research
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:research-information.bris....
Last time updated on 17/01/2017
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1136%2Fbmjopen-201...
Last time updated on 01/04/2019
Name not available
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:researchportal.port.ac.uk:...
Last time updated on 11/11/2016
UWE Bristol Research Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:uwe-repository.worktribe.c...
Last time updated on 08/06/2020